Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE
HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen...
Source: globenewswire.com
Page 3 - Jon Olav News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jon Olav. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jon Olav Today - Breaking & Trending Today
Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen receptor inhibition in preclinical... | May 30, 2023
Source: marketscreener.com
Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT
The first quarter of 2023 shows a very good development for HBC. Revenues came in at NOK 44m vs NOK 30m last year, a growth of 48 % YoY and 32 % QoQ. The underlying growth we are seeing is coming from... | May 12, 2023
Source: marketscreener.com
Hofseth Biocare ASA: DISCLOSURE OF VOTING PROXIES
Reference is made to the notice from Hofseth BioCare ASA for an annual general meeting to be held on 28 April 2023 . Torill Standal Eliassen, board member of the Company, has received proxies to... | April 28, 2023
Source: marketscreener.com
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
Hofseth BioCare ASA held its Annual General Meeting on 28 April 2023. 253,351,609 shares, amounting to 64.13 per cent of the share capital, were represent in the meeting or by proxy. All proposals... | April 28, 2023
Source: marketscreener.com